DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $477,000 | -46.0% | 23,671 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $883,000 | +55.2% | 23,671 | +6.3% | 0.00% | +100.0% |
| Q1 2021 | $569,000 | +16.8% | 22,264 | +0.7% | 0.00% | 0.0% |
| Q4 2020 | $487,000 | +22.4% | 22,114 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $398,000 | -27.2% | 22,114 | +2.7% | 0.00% | 0.0% |
| Q2 2020 | $547,000 | +38.5% | 21,524 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $395,000 | -16.7% | 21,524 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $474,000 | +54.9% | 21,524 | +0.9% | 0.00% | 0.0% |
| Q3 2019 | $306,000 | -8.9% | 21,334 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $336,000 | +25.8% | 21,334 | +17.0% | 0.00% | 0.0% |
| Q1 2019 | $267,000 | +36.9% | 18,234 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $195,000 | -15.9% | 18,234 | +19.9% | 0.00% | 0.0% |
| Q3 2018 | $232,000 | +30.3% | 15,210 | +4.7% | 0.00% | – |
| Q2 2018 | $178,000 | – | 14,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|